Malaria Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Malaria Clinical Trial Report Overview
A total of 1,673 malaria clinical trials were conducted as of January 2024. The malaria clinical trial report provides a comprehensive understanding of the malaria clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · Kenya
· United States · Burkina Faso · Uganda · Tanzania |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · GSK plc
· Sanaria Inc · Novartis AG · Nucleus Network Ltd · Sanofi |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Malaria Clinical Trials Segmentation by Regions and Countries
Middle East and Africa led the malaria clinical trials landscape with more than 40% of the clinical trials conducted as of January 2024.
The key regions considered for Malaria clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In the country-wise analysis, Kenya had the highest number of malaria clinical trials, as of January 2024. Kenya also had the highest average patient enrollment of malaria clinical trials, during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United Kingdom had the highest proportion of Malaria to Infectious Disease clinical trials as of January 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia had the highest proportion of Malaria to Infectious Disease clinical trials as of January 2024.
Malaria Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Malaria Clinical Trials
Download a Free Sample Report
Malaria Clinical Trials Segmentation by Sponsor Types
The key sponsor types for malaria clinical trials are company, institution, and the government. As of January 2024, more than 50% of malaria clinical trials conducted were sponsored by institution sponsor type, followed by the company.
Malaria Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Insights into the Malaria Clinical Trials Sponsor Types
Malaria Clinical Trials - Competitive Landscape
In 2023, GSK plc conducted the highest number of Malaria clinical trials
A few of the leading sponsors for malaria clinical trials are:
- GSK plc
- Sanaria Inc
- Novartis AG
- Nucleus Network Ltd
- Sanofi
Malaria Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy the Full Report to Know More About the Leading Players of Malaria Clinical Trials
Segments Covered in the Report
Malaria Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Malaria Clinical Trials Country Outlook (2023)
- Kenya
- United States
- Burkina Faso
- Uganda
- Tanzania
Malaria Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies with regard to investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
Sanaria Inc
Novartis AG
Nucleus Network Ltd
Sanofi
Shin Poong Pharm Co Ltd
Pfizer Inc
Sun Pharmaceutical Industries Ltd
IPCA Laboratories Ltd
Richmond Pharmacology Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of malaria clinical trials in January 2024?
The Middle East and Africa accounted for the highest number of malaria clinical trials as of January 2024.
-
Which country conducted the highest number of malaria clinical trials in January 2024?
Kenya conducted the highest number of malaria clinical trials as of January 2024.
-
Which sponsor type was the most prominent in the malaria clinical trials in January 2024?
As of January 2024, most of the malaria clinical trials conducted were sponsored by instituton sponsor type.
-
Which are the leading sponsors of malaria clinical trials?
A few of the leading sponsors of malaria clinical trials are GSK plc, Sanaria Inc, Novartis AG, Nucleus Network Ltd, and Sanofi, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.